Tom Daniel, MD, President, Research and Early Development has been appointed as Chairman of Celgene Research, a newly created position, and will oversee strategic initiatives and investments in Celgene Corporation's research and collaboration portfolio. Rupert Vessey, MA, BM BCh, FRCP, DPhil, will succeed Tom Daniel as President, Research and Early Development, and will be responsible for leading the execution of discovery and development programs across the company's portfolio ensuring that Celgene capitalizes on the potential of its internal and partnered opportunities.